|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lifestyle intervention for prevention of type 2 diabetes in primary health care: one year follow-up of the Finnish National Dia- betes Prevention Program (FIN-D2D) 显示文摘 | Saaristo T Moilanen L Korpi-Hyovalti E | 2010 | Diabetes Care2010，33，10： | 1 |
| 2 | Lumpectomy with or without postoperative radiotherapy for breast cancer with favorable prognostic features : results of a randomized study 显示文摘 | Holli K Saaristo R Isola J | 2001 | Br J Cancer2001，84，2： | 1 |
| 3 | VEGF-C and VEGF- D expression in ncuroendocrine cells and their receptor,VEG- FR 3, in fenestrated blood vessels in human tissues显示文摘 | Partanen T A Arola J Saaristo A | 2000 | FASEB J2000，14，13： | 1 |
| 4 | VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor,VEGFR-3,in fenestrated blood vessels in human tissues显示文摘 | Partanen T Arola J Saaristo A | 2000 | FASEB J2000，14，： | 1 |
| 5 | Lymphangiogenic gene therapy with minimal blood vascular side effects 显示文摘 | Saaristo A Veikkola T Tammela T | 2002 | JEM2002，196，6： | 1 |
| 6 | Vascular endothelial growth factor-C and its receptor Fit-4 in the nasal mucosa and in nasopharyngeal tumors显示文摘 | Saaristo A Taina A Johanna P | 2000 | Am J Pathol2000，157，1： | 1 |
| 7 | VEGF-C andVEGF-D expression in neuroendocrine cells and their receptor,VEGFR-3,in fenestrated blood vessels in human tissues显示文摘 | PartanenTA Arola J Saaristo A | | 0，，： | 1 |
| 8 | Insights into the molecular pathogenesis and targeted treatment of lymphedema显示文摘 | Saaristo A Karkkainen MJ Mitalo K | 2002 | Ann N Y Acad Sci2002，979，： | 1 |
| 9 | Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis显示文摘 | Terhi Karpanen Kari Alitalo | 2000 | Oncogene2000，19，： | 1 |
| 10 | VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues显示文摘 | PARTANEN T A AROLA J SAARISTO A | 2000 | FASEB J2000，14，： | 1 |
| 11 | VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor,VEGFR-3,in fenestrated blood vessels in human tissues显示文摘 | Partanen TA Aroka J Saaristo A | 2000 | FASEB J2000，14，13： | 1 |
| 12 | Mechanisms of angiogenesis and their use in the inhibition of tumor and metastasis显示文摘 | SAARISTO A KARPANEN T ALITALO K | 2000 | Oncogene2000，19，53： | 1 |
| 13 | Mierovascular breast reconstraction and lymph node transfer for postmastectomy lymphedema patients 显示文摘 | Saaristo AM Niemi TS Viitanen TP | 2012 | Ann Surg2012，255，3： | 1 |
| 14 | Early treatment with antibiot- ics reduces the need for surgery in acute necrotizing pancreatitis--a single- center randomized study显示文摘 | Nordback I Sand J Saaristo R | 2001 | J Gastrointest Surg2001，5，2： | 1 |
| 15 | Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis显示文摘 | Saaristo A Karpanen T Alitalo K | 2000 | Oncogene2000，19，53： | 1 |
| 16 | VEGF-C and VEGF -D ex- pression in neuroendocrine cells and their receptor, VEGFR - 3, in fe- nestrated blood vessels in human tissues 显示文摘 | Partanen TA Arola J Saaristo A | 2000 | FASEB J2000，14，13： | 1 |
| 17 | Growth factor therapy and autolo- gous lymph node transfer in lymphedema显示文摘 | Hartiala P Saaristo A M | 2010 | Trends Car-dio Med2010，20，8： | 1 |
| 18 | A model for gene therapy of human hereditary lymphedema显示文摘 | Karkkainen MJ Saaristo A Jussila L | 2001 | Proc Natl Acad Sci USA2001，98，12： | 1 |
| 19 | VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor,VEGF-3 in fenestratted endothelia in human tissue显示文摘 | Partanen TA Arola J Saaristo A | 2000 | FASEB J2000，14，13： | 1 |
| 20 | VEGF-C and VEGF-D expression in neuroendocrine cells and the irreceptor, VEGFR-3, in fenestrated blood vessels in human tissues 显示文摘 | Partanen T A Arola J Saaristo A | 2000 | FASEB J2000，14，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员